Top compounds associated with response to MYLPF


Feature Type Standardized
Nominal ANOVA
mRNA FMK GDSC1000 pan-cancer AAC 0.14 0.0002
mRNA Docetaxel gCSI pan-cancer AAC -0.16 0.003
mRNA SN-38 GDSC1000 pan-cancer AAC -0.098 0.004
mRNA paclitaxel gCSI pan-cancer AAC -0.14 0.007
mRNA Crizotinib gCSI pan-cancer AAC -0.15 0.009
mRNA PD173074 GDSC1000 pan-cancer AAC -0.093 0.01
mRNA Doxorubicin gCSI pan-cancer AAC -0.13 0.01
mRNA AZD0530 CCLE pan-cancer AAC 0.12 0.01
mRNA Irinotecan gCSI pan-cancer AAC -0.13 0.01
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.081 0.01
Download CSV